Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mortimer

Showing results (241-250 of 262) with videos related to

Pageof 27
Sort By:
Mbio|July 17, 2014
Multisubstrate isotope labeling and metagenomic analysis of active soil bacterial communitiesY Verastegui, J Cheng, K Engel, et al.
JCO Precision Oncology|September 14, 2020
Mechanisms of Acquired Resistance to Savolitinib, a Selective MET Inhibitor in <i>MET</i>-Amplified Gastric CancerMelanie M Frigault, Aleksandra Markovets, Barrett Nuttall, et al.
Translational Oncology|January 30, 2019
Combination of Docetaxel Plus Savolitinib in Refractory Cancer Patients: A Report on Phase I TrialSeung Tae Kim, Sujin Lee, Minhwa Park, et al.
Plos One|October 13, 2022
Investigation of clinical characteristics and genome associations in the 'UK Lipoedema' cohortDionysios Grigoriadis, Ege Sackey, Katie Riches, et al.
American Journal of Human Genetics|July 27, 1999
A gene for lymphedema-distichiasis maps to 16q24.3J Mangion, N Rahman, S Mansour, et al.
The New England Journal of Medicine|May 3, 2013
Penicillin to prevent recurrent leg cellulitisKim S Thomas, Angela M Crook, Andrew J Nunn, et al.
Cancer|October 16, 2023
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancerSehhoon Park, Yu Jung Kim, Young Joo Min, et al.
Cancer|June 26, 2020
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapySehhoon Park, Joonho Shim, Peter G S Mortimer, et al.
Nature Communications|September 4, 2015
Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalisElisavet Fotiou, Silvia Martin-Almedina, Michael A Simpson, et al.
Journal for Immunotherapy of Cancer|July 5, 2022
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancerMinsuk Kwon, Gahyun Kim, Ryul Kim, et al.
Pageof 27

Showing results (241-250 of 262) with videos related to

Sort By:
Pageof 27
Mbio|July 17, 2014
Multisubstrate isotope labeling and metagenomic analysis of active soil bacterial communitiesY Verastegui, J Cheng, K Engel, et al.
JCO Precision Oncology|September 14, 2020
Mechanisms of Acquired Resistance to Savolitinib, a Selective MET Inhibitor in <i>MET</i>-Amplified Gastric CancerMelanie M Frigault, Aleksandra Markovets, Barrett Nuttall, et al.
Translational Oncology|January 30, 2019
Combination of Docetaxel Plus Savolitinib in Refractory Cancer Patients: A Report on Phase I TrialSeung Tae Kim, Sujin Lee, Minhwa Park, et al.
Plos One|October 13, 2022
Investigation of clinical characteristics and genome associations in the 'UK Lipoedema' cohortDionysios Grigoriadis, Ege Sackey, Katie Riches, et al.
American Journal of Human Genetics|July 27, 1999
A gene for lymphedema-distichiasis maps to 16q24.3J Mangion, N Rahman, S Mansour, et al.
The New England Journal of Medicine|May 3, 2013
Penicillin to prevent recurrent leg cellulitisKim S Thomas, Angela M Crook, Andrew J Nunn, et al.
Cancer|October 16, 2023
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancerSehhoon Park, Yu Jung Kim, Young Joo Min, et al.
Cancer|June 26, 2020
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapySehhoon Park, Joonho Shim, Peter G S Mortimer, et al.
Nature Communications|September 4, 2015
Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalisElisavet Fotiou, Silvia Martin-Almedina, Michael A Simpson, et al.
Journal for Immunotherapy of Cancer|July 5, 2022
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancerMinsuk Kwon, Gahyun Kim, Ryul Kim, et al.
Pageof 27